NCT05397587View on ClinicalTrials.gov

An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

474

Participants

Timeline

Start Date

July 30, 2022

Primary Completion Date

July 30, 2025

Study Completion Date

October 30, 2025

Conditions

Hand, Foot and Mouth Disease

Interventions

BIOLOGICAL

Experimental Vaccine

The EV71 vaccine was manufactured by Sinovac Biotech Co., Ltd and inactivated EV71 virus antigen was no less than 3.0EU in 0.5 mL of aluminium hydroxide solution per injection.

BIOLOGICAL

Control Vaccine

The EV71 vaccine was manufactured by Institute of Medical Biology,Chinese Academy of Medical Sciences ,and inactivated EV71 virus antigen was no less than 3.0EU in 0.5 mL of aluminium hydroxide solution per injection.

Trial Locations (1)

675800

Yun County Center for Disease Control and Prevention, Lincang

All Listed Sponsors

lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT05397587 - An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) | Biotech Hunter | Biotech Hunter